Scooter, huge favor to ask: can you point me to the blog you speak of, and YouTube vid's? I'm also curious of your situation. In my case, severe chondromalacia from running overuse. Lacerations under each knee cap (bone on bone). I have all of your same challenges. I'm young and active, and super frustrated. All: I, too, am interested in knowing cost of this procedure. I recalled hearing $10K at one point. Has this changed?
Scooter, I beleive Regenexx now has several regenexx treatments to offer so they have a fee range depending on what the protocol the doctor recommends for each patient. I was told it is between $1200 and $6000 per treatment.
I saw these guys back in September of last year pre-FDA smack down and was quoted the usual 6K plus or so per knee. I'd have to dig out the paper work to say for sure. What these guys never mentioned during my consult was the pending FDA situation. They actually said I'd be a great candidate without even looking at the MRI's I had brought in. Had I gone through with it, my expensive stem cells would have been under house arrest cryogenically and legally unavailable. I've asked around about the Centeno-Shultz operation and from several reputable orthopedic sources, I obviously don't want to mention who, the consensus seems to be the science is sound, the execution is questionable. I can't attest to the efficacy or lack there of of the procedure. What I can say is good for them for pushing the science envelope but my feeling after consulting with them is they are first and foremost brilliant marketers looking to take your money in lieu of getting funding for an FDA study. Yes FDA can hold back medicine. I agree but if Centeno-Shultz had such an interest in pushing the envelope, how about some skin in the game themselves rather than just an over-willingness to take your money and try out their methodology. Good luck but caveat celltor - let the stem cell buyer beware. If any of you proceed or have I'd love to hear your outcomes. I've been traveling the PRP route with little success thus far.